Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 6/2018

05.02.2018 | Original Article

Predictors of Short-Term Readmission After Pancreaticoduodenectomy

verfasst von: Rajesh Ramanathan, Travis Mason, Luke G. Wolfe, Brian J. Kaplan

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Readmissions are a common complication after pancreaticoduodenectomy and are increasingly being used as a performance metric affecting quality assessment, public reporting, and reimbursement. This study aims to identify general and pancreatectomy-specific factors contributing to 30-day readmission after pancreaticoduodenectomy, and determine the additive value of incorporating pancreatectomy-specific factors into a large national dataset.

Methods

Prospective American College of Surgeons-National Surgical Quality Improvement Project (ACS-NSQIP) data were retrospectively analyzed for patients who underwent pancreaticoduodenectomy (PD) between 2011 and 2015. Additionally, a subset of patients with pancreatectomy-targeted data between 2014 and 2015 were analyzed.

Results

Outcomes of 18,440 pancreaticoduodenectomies were analyzed, and found to have an 18.7% overall readmission rate. Multivariable modeling with pancreatectomy-specific variables increased the predictive value of the model (area under receiver operator characteristic 0.66 to 0.73). Statistically significant independent contributors to readmission included renal insufficiency, sepsis, septic shock, organ space infection, dehiscence, venous thromboembolism, pancreatic fistula, delayed gastric emptying, need for percutaneous drainage, and reoperation.

Conclusions

Large registry analyses of pancreatectomy outcomes are markedly improved by the incorporation of granular procedure-specific data. These data emphasize the need for prevention and careful management of perioperative infectious complications, fluid management, thromboprophylaxis, and pancreatic fistulae.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226(3):248–57; discussion 257-60.CrossRefPubMedPubMedCentral Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226(3):248–57; discussion 257-60.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Newhook TE, LaPar DJ, Lindberg JM, Bauer TW, Adams RB, Zaydfudim VM. Morbidity and mortality of pancreaticoduodenectomy for benign and premalignant pancreatic neoplasms. J Gastrointest Surg. 2015;19(6):1072–1077.CrossRefPubMed Newhook TE, LaPar DJ, Lindberg JM, Bauer TW, Adams RB, Zaydfudim VM. Morbidity and mortality of pancreaticoduodenectomy for benign and premalignant pancreatic neoplasms. J Gastrointest Surg. 2015;19(6):1072–1077.CrossRefPubMed
4.
Zurück zum Zitat Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg. 1999;229(6):790–9; discussion 799-800.CrossRefPubMedPubMedCentral Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg. 1999;229(6):790–9; discussion 799-800.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Ahmad SA, Edwards MJ, Sutton JM, et al. Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients. Ann Surg. 2012;256(3):529–537.CrossRefPubMed Ahmad SA, Edwards MJ, Sutton JM, et al. Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients. Ann Surg. 2012;256(3):529–537.CrossRefPubMed
6.
Zurück zum Zitat Gawlas I, Sethi M, Winner M, et al. Readmission after pancreatic resection is not an appropriate measure of quality. Ann Surg Oncol. 2013;20(6):1781–1787.CrossRefPubMed Gawlas I, Sethi M, Winner M, et al. Readmission after pancreatic resection is not an appropriate measure of quality. Ann Surg Oncol. 2013;20(6):1781–1787.CrossRefPubMed
8.
Zurück zum Zitat Medicaid Program. Payment adjustment for provider-preventable conditions including health care-acquired conditions.. 2011;Vol. 76, No. 108. Medicaid Program. Payment adjustment for provider-preventable conditions including health care-acquired conditions.. 2011;Vol. 76, No. 108.
11.
Zurück zum Zitat Agency for Healthcare Research and Quality. AHRQ quality indicators: Guide to patient safety indicators. 2003(March). Agency for Healthcare Research and Quality. AHRQ quality indicators: Guide to patient safety indicators. 2003(March).
12.
Zurück zum Zitat Centers for Medicare and Medicaid Services (CMS), HHS. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Fed Regist. 2007;72(162):47129–48175. Centers for Medicare and Medicaid Services (CMS), HHS. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Fed Regist. 2007;72(162):47129–48175.
13.
Zurück zum Zitat Centers for Medicare and Medicaid Services (CMS), HHS. Hospital-acquired condition reduction program fiscal year 2017 fact sheet. 2017. Centers for Medicare and Medicaid Services (CMS), HHS. Hospital-acquired condition reduction program fiscal year 2017 fact sheet. 2017.
14.
Zurück zum Zitat Ramanathan R, Leavell P, Stockslager G, Mays C, Harvey D, Duane TM. Validity of agency for healthcare research and quality patient safety indicators at an academic medical center. Am Surg. 2013;79(6):578–582.PubMed Ramanathan R, Leavell P, Stockslager G, Mays C, Harvey D, Duane TM. Validity of agency for healthcare research and quality patient safety indicators at an academic medical center. Am Surg. 2013;79(6):578–582.PubMed
15.
Zurück zum Zitat Duane TM, Ramanathan R, Leavell P, Mays C, Ober J. CAUTIs and CLABSIs: do physicians REALLY know what they are? Surg Infect (Larchmt). 2016;17(1):13–16.CrossRefPubMed Duane TM, Ramanathan R, Leavell P, Mays C, Ober J. CAUTIs and CLABSIs: do physicians REALLY know what they are? Surg Infect (Larchmt). 2016;17(1):13–16.CrossRefPubMed
16.
Zurück zum Zitat Duane TM, Ramanathan R, Leavell P, Mays C, Harvey D. Concurrent surgical patient safety indicator evaluation results in more accurate reporting and reimbursement. Am Surg. 2014;80(8):776–777.PubMed Duane TM, Ramanathan R, Leavell P, Mays C, Harvey D. Concurrent surgical patient safety indicator evaluation results in more accurate reporting and reimbursement. Am Surg. 2014;80(8):776–777.PubMed
17.
Zurück zum Zitat Ramanathan R, Leavell P, Stockslager G, Mays C, Harvey D, Duane TM. Validity of ICD-9-CM screening for sepsis in surgical mortalities. Surgical infections. 2014(in press). Ramanathan R, Leavell P, Stockslager G, Mays C, Harvey D, Duane TM. Validity of ICD-9-CM screening for sepsis in surgical mortalities. Surgical infections. 2014(in press).
18.
Zurück zum Zitat Rosen AK, Itani KM, Cevasco M, et al. Validating the patient safety indicators in the veterans health administration: do they accurately identify true safety events? Med Care. 2012;50(1):74–85.CrossRefPubMed Rosen AK, Itani KM, Cevasco M, et al. Validating the patient safety indicators in the veterans health administration: do they accurately identify true safety events? Med Care. 2012;50(1):74–85.CrossRefPubMed
19.
Zurück zum Zitat Kaafarani HM, Borzecki AM, Itani KM, et al. Validity of selected patient safety indicators: opportunities and concerns. J Am Coll Surg. 2011;212(6):924–934.CrossRefPubMed Kaafarani HM, Borzecki AM, Itani KM, et al. Validity of selected patient safety indicators: opportunities and concerns. J Am Coll Surg. 2011;212(6):924–934.CrossRefPubMed
20.
Zurück zum Zitat Ramanathan R, Leavell P, Wolfe LG, Duane TM. Agency for healthcare research and quality patient safety indicators and mortality in surgical patients. Am Surg. 2014;80(8):801–804.PubMed Ramanathan R, Leavell P, Wolfe LG, Duane TM. Agency for healthcare research and quality patient safety indicators and mortality in surgical patients. Am Surg. 2014;80(8):801–804.PubMed
21.
Zurück zum Zitat Ramanathan R, Leavell P, Mays C, Duane TM. Impact of sepsis on surgical outcomes. Surg Infect (Larchmt). 2015;16(4):405–409.CrossRefPubMed Ramanathan R, Leavell P, Mays C, Duane TM. Impact of sepsis on surgical outcomes. Surg Infect (Larchmt). 2015;16(4):405–409.CrossRefPubMed
22.
Zurück zum Zitat Sellers MM, Merkow RP, Halverson A, et al. Validation of new readmission data in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg. 2013;216(3):420–427.CrossRefPubMed Sellers MM, Merkow RP, Halverson A, et al. Validation of new readmission data in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg. 2013;216(3):420–427.CrossRefPubMed
23.
Zurück zum Zitat Fong ZV, Ferrone CR, Thayer SP, et al. Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?: a 10-year contemporary experience with 1,173 patients at the massachusetts general hospital. J Gastrointest Surg. 2014;18(1):137–44; discussion 144-5.CrossRefPubMed Fong ZV, Ferrone CR, Thayer SP, et al. Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?: a 10-year contemporary experience with 1,173 patients at the massachusetts general hospital. J Gastrointest Surg. 2014;18(1):137–44; discussion 144-5.CrossRefPubMed
24.
Zurück zum Zitat Kastenberg ZJ, Morton JM, Visser BC, Norton JA, Poultsides GA. Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric? HPB (Oxford). 2013;15(2):142–148.CrossRef Kastenberg ZJ, Morton JM, Visser BC, Norton JA, Poultsides GA. Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric? HPB (Oxford). 2013;15(2):142–148.CrossRef
25.
Zurück zum Zitat Kent TS, Sachs TE, Callery MP, Vollmer CM,Jr. Readmission after major pancreatic resection: a necessary evil? J Am Coll Surg. 2011;213(4):515–523.CrossRefPubMed Kent TS, Sachs TE, Callery MP, Vollmer CM,Jr. Readmission after major pancreatic resection: a necessary evil? J Am Coll Surg. 2011;213(4):515–523.CrossRefPubMed
26.
Zurück zum Zitat Yermilov I, Bentrem D, Sekeris E, et al. Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisal. Ann Surg Oncol. 2009;16(3):554–561.CrossRefPubMed Yermilov I, Bentrem D, Sekeris E, et al. Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisal. Ann Surg Oncol. 2009;16(3):554–561.CrossRefPubMed
27.
Zurück zum Zitat Reddy DM, Townsend CM,Jr, Kuo YF, Freeman JL, Goodwin JS, Riall TS. Readmission after pancreatectomy for pancreatic cancer in Medicare patients. J Gastrointest Surg. 2009;13(11):1963–74; discussion 1974-5.CrossRefPubMedPubMedCentral Reddy DM, Townsend CM,Jr, Kuo YF, Freeman JL, Goodwin JS, Riall TS. Readmission after pancreatectomy for pancreatic cancer in Medicare patients. J Gastrointest Surg. 2009;13(11):1963–74; discussion 1974-5.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Emick DM, Riall TS, Cameron JL, et al. Hospital readmission after pancreaticoduodenectomy. J Gastrointest Surg. 2006;10(9):1243–52; discussion 1252-3.CrossRefPubMed Emick DM, Riall TS, Cameron JL, et al. Hospital readmission after pancreaticoduodenectomy. J Gastrointest Surg. 2006;10(9):1243–52; discussion 1252-3.CrossRefPubMed
29.
Zurück zum Zitat Epelboym I, Gawlas I, Lee JA, Schrope B, Chabot JA, Allendorf JD. Limitations of ACS-NSQIP in reporting complications for patients undergoing pancreatectomy: underscoring the need for a pancreatectomy-specific module. World J Surg. 2014;38(6):1461–1467.CrossRefPubMed Epelboym I, Gawlas I, Lee JA, Schrope B, Chabot JA, Allendorf JD. Limitations of ACS-NSQIP in reporting complications for patients undergoing pancreatectomy: underscoring the need for a pancreatectomy-specific module. World J Surg. 2014;38(6):1461–1467.CrossRefPubMed
30.
Zurück zum Zitat Grewal SS, McClaine RJ, Schmulewitz N, et al. Factors associated with recidivism following pancreaticoduodenectomy. HPB (Oxford). 2011;13(12):869–875.CrossRefPubMedPubMedCentral Grewal SS, McClaine RJ, Schmulewitz N, et al. Factors associated with recidivism following pancreaticoduodenectomy. HPB (Oxford). 2011;13(12):869–875.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Cocoros NM, Klompas M. Ventilator-associated events and their prevention. Antimicrob Resist Infect Control. 2016;14(5):43. Cocoros NM, Klompas M. Ventilator-associated events and their prevention. Antimicrob Resist Infect Control. 2016;14(5):43.
32.
Zurück zum Zitat Passaro L, Harbarth S, Landelle C. Prevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative review. BMJ Open. 2014;25(4):e006065. Passaro L, Harbarth S, Landelle C. Prevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative review. BMJ Open. 2014;25(4):e006065.
33.
Zurück zum Zitat Herzer KR, Niessen L, Constenla DO, Ward WJ Jr, Pronovost PJ. Cost-effectiveness of a quality improvement programme to reduce central line-associated bloodstream infections in intensive care units in the USA. Pancreatology. 2017;17(5):805–813.CrossRef Herzer KR, Niessen L, Constenla DO, Ward WJ Jr, Pronovost PJ. Cost-effectiveness of a quality improvement programme to reduce central line-associated bloodstream infections in intensive care units in the USA. Pancreatology. 2017;17(5):805–813.CrossRef
34.
Zurück zum Zitat Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical site infections. Ann Surg. 2011;253(6):1082–1093.CrossRefPubMed Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical site infections. Ann Surg. 2011;253(6):1082–1093.CrossRefPubMed
35.
Zurück zum Zitat Holubar SD, Hedrick T, Gupta R, et al. American society for enhanced recovery (ASER) and perioperative quality initiative (POQI) joint consensus statement on prevention of postoperative infection within an enhanced recovery pathway for elective colorectal surgery. Perioper Med (Lond). 2017;6:4-017-0059-2. eCollection 2017. Holubar SD, Hedrick T, Gupta R, et al. American society for enhanced recovery (ASER) and perioperative quality initiative (POQI) joint consensus statement on prevention of postoperative infection within an enhanced recovery pathway for elective colorectal surgery. Perioper Med (Lond). 2017;6:4-017-0059-2. eCollection 2017.
36.
Zurück zum Zitat Causey MW, Maykel JA, Hatch Q, Miller S, Steele SR. Identifying risk factors for renal failure and myocardial infarction following colorectal surgery. J Surg Res. 2011;170(1):32–37.CrossRefPubMed Causey MW, Maykel JA, Hatch Q, Miller S, Steele SR. Identifying risk factors for renal failure and myocardial infarction following colorectal surgery. J Surg Res. 2011;170(1):32–37.CrossRefPubMed
37.
Zurück zum Zitat Ramanathan R, Gu Z, Limkemann AJ, et al. Association between interruptions in chemical prophylaxis and VTE formation. Am Surg. 2015;81(7):732–737.PubMed Ramanathan R, Gu Z, Limkemann AJ, et al. Association between interruptions in chemical prophylaxis and VTE formation. Am Surg. 2015;81(7):732–737.PubMed
38.
Zurück zum Zitat Ramanathan R, Lee N, Duane TM, et al. Correlation of venous thromboembolism prophylaxis and electronic medical record alerts with incidence among surgical patients. Surgery. 2016;160(5):1202–1210.CrossRefPubMed Ramanathan R, Lee N, Duane TM, et al. Correlation of venous thromboembolism prophylaxis and electronic medical record alerts with incidence among surgical patients. Surgery. 2016;160(5):1202–1210.CrossRefPubMed
39.
Zurück zum Zitat Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM,Jr. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013;216(1):1–14.CrossRefPubMed Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM,Jr. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013;216(1):1–14.CrossRefPubMed
40.
Zurück zum Zitat Pratt WB, Callery MP, Vollmer CM, Jr. Risk prediction for development of pancreatic fistula using the ISGPF classification scheme. World J Surg. 2008;32(3):419–428.CrossRefPubMed Pratt WB, Callery MP, Vollmer CM, Jr. Risk prediction for development of pancreatic fistula using the ISGPF classification scheme. World J Surg. 2008;32(3):419–428.CrossRefPubMed
41.
Zurück zum Zitat Ricci C, Casadei R, Taffurelli G, et al. Is pancreaticogastrostomy safer than pancreaticojejunostomy after pancreaticoduodenectomy? A meta-regression analysis of randomized clinical trials. Biomed Res Int. 2017;(2017):1367238. Ricci C, Casadei R, Taffurelli G, et al. Is pancreaticogastrostomy safer than pancreaticojejunostomy after pancreaticoduodenectomy? A meta-regression analysis of randomized clinical trials. Biomed Res Int. 2017;(2017):1367238.
42.
Zurück zum Zitat Hong S, Wang H, Yang S, Yang K. External stent versus no stent for pancreaticojejunostomy: a meta-analysis of randomized controlled trials. J Gastrointest Surg. 2009;13(7):1184–6.CrossRef Hong S, Wang H, Yang S, Yang K. External stent versus no stent for pancreaticojejunostomy: a meta-analysis of randomized controlled trials. J Gastrointest Surg. 2009;13(7):1184–6.CrossRef
43.
Zurück zum Zitat Zhao Y, Zhang J, Lan Z, et al. Are internal or external pancreatic duct stents the preferred choice for patients undergoing pancreaticoduodenectomy? a meta-analysis. J Gastrointest Surg. 2013;17(8):1516–25.CrossRef Zhao Y, Zhang J, Lan Z, et al. Are internal or external pancreatic duct stents the preferred choice for patients undergoing pancreaticoduodenectomy? a meta-analysis. J Gastrointest Surg. 2013;17(8):1516–25.CrossRef
44.
Zurück zum Zitat Schulick RD, Yoshimura K. Stents, glue, etc.: is anything proven to help prevent pancreatic leaks/fistulae? Ann Surg. 2016;264(3):528–37.CrossRef Schulick RD, Yoshimura K. Stents, glue, etc.: is anything proven to help prevent pancreatic leaks/fistulae? Ann Surg. 2016;264(3):528–37.CrossRef
45.
Zurück zum Zitat Witzigmann H, Diener MK, Kienkötter S, et al. No need for routine drainage after pancreatic head resection: the dual-center, randomized, controlled PANDRA trial (ISRCTN04937707). J Surg Res. 2016;202(2):380–8.CrossRef Witzigmann H, Diener MK, Kienkötter S, et al. No need for routine drainage after pancreatic head resection: the dual-center, randomized, controlled PANDRA trial (ISRCTN04937707). J Surg Res. 2016;202(2):380–8.CrossRef
46.
Zurück zum Zitat Hanna MM, Gadde R, Allen CJ, et al. Delayed gastric emptying after pancreaticoduodenectomy. World J Surg. 2014;38(11):2960–6.CrossRef Hanna MM, Gadde R, Allen CJ, et al. Delayed gastric emptying after pancreaticoduodenectomy. World J Surg. 2014;38(11):2960–6.CrossRef
47.
Zurück zum Zitat Braga M, Pecorelli N, Ariotti R, et al. Enhanced recovery after surgery pathway in patients undergoing pancreaticoduodenectomy. Br J Surg. 2015;102(13):1676–83.CrossRef Braga M, Pecorelli N, Ariotti R, et al. Enhanced recovery after surgery pathway in patients undergoing pancreaticoduodenectomy. Br J Surg. 2015;102(13):1676–83.CrossRef
48.
Zurück zum Zitat Joliat GR, Labgaa I, Petermann D, et al. Cost-benefit analysis of an enhanced recovery protocol for pancreaticoduodenectomy. Infect Dis Clin North Am. 2016;30(4):887–908.CrossRef Joliat GR, Labgaa I, Petermann D, et al. Cost-benefit analysis of an enhanced recovery protocol for pancreaticoduodenectomy. Infect Dis Clin North Am. 2016;30(4):887–908.CrossRef
49.
Zurück zum Zitat McMillan RR, Berger A, Sima CS, et al. Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies. Ann Thorac Surg. 2014;98(5):1769–74; discussion 1774-5.CrossRefPubMedPubMedCentral McMillan RR, Berger A, Sima CS, et al. Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies. Ann Thorac Surg. 2014;98(5):1769–74; discussion 1774-5.CrossRefPubMedPubMedCentral
Metadaten
Titel
Predictors of Short-Term Readmission After Pancreaticoduodenectomy
verfasst von
Rajesh Ramanathan
Travis Mason
Luke G. Wolfe
Brian J. Kaplan
Publikationsdatum
05.02.2018
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 6/2018
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-018-3700-6

Weitere Artikel der Ausgabe 6/2018

Journal of Gastrointestinal Surgery 6/2018 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.